Posizolid
Posizolid
Posizolid (pronounced poh-zih-zoh-lid) is a novel antibiotic currently under development for the treatment of bacterial infections resistant to other antibiotics.
Etymology
The name "Posizolid" is derived from the class of antibiotics it belongs to, known as oxazolidinones. The prefix "Posi-" is likely a proprietary designation by the developing company.
Definition
Posizolid is a synthetic antibacterial agent of the oxazolidinone class. It is currently in the late stages of clinical development and is being investigated for its potential to treat infections caused by multi-drug resistant Gram-positive bacteria.
Mechanism of Action
Posizolid works by inhibiting protein synthesis in bacteria, thereby stopping their growth and proliferation. It does this by binding to the bacterial ribosome, a complex molecular machine that synthesizes proteins.
Related Terms
- Oxazolidinones: A class of antibiotics to which Posizolid belongs.
- Protein synthesis: The process by which proteins are produced in cells.
- Ribosome: A complex molecular machine found in all living cells that is responsible for synthesizing proteins.
- Gram-positive bacteria: A group of bacteria that are generally more susceptible to antibiotics than Gram-negative bacteria.
See Also
- Linezolid: Another oxazolidinone antibiotic that is currently on the market.
- Tedizolid: A second-generation oxazolidinone antibiotic that is also currently available.
External links
- Medical encyclopedia article on Posizolid
- Wikipedia's article - Posizolid
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski